{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T04:10:21Z","timestamp":1719807021407},"reference-count":35,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.8026","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T08:37:29Z","timestamp":1518424649000},"source":"Crossref","is-referenced-by-count":2,"title":["\u03b3\u03b4 T cell-mediated individualized immunotherapy for hepatocellular carcinoma considering clinicopathological characteristics and immunosuppressive factors"],"prefix":"10.3892","author":[{"given":"Wei","family":"Tian","sequence":"first","affiliation":[{"name":"The First Clinical Medical School of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyi","family":"Shi","sequence":"additional","affiliation":[{"name":"Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongren","family":"Ren","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiefeng","family":"He","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Shanxi Dayi Hospital, Shanxi Academy of Medical Sciences, Taiyuan, Shanxi 030032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoliang","family":"Zhao","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"key":"key20200714003137_b1-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20200714003137_b2-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/bjh.12090","article-title":"Anti-tumour immunotherapy with V\u03b39V\u03b42 T lymphocytes: From the bench to the bedside","volume":"160","author":"Braza","year":"2013","journal-title":"Br J Haematol"},{"key":"key20200714003137_b3-ol-0-0-8026","first-page":"10","article-title":"Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by V\u03b39V\u03b42 T cells","volume":"10","author":"Dhar","year":"2010","journal-title":"Cancer Immun"},{"key":"key20200714003137_b4-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"119","DOI":"10.7150\/ijbs.7823","article-title":"\u03b3\u03b4 T cells and their potential for immunotherapy","volume":"10","author":"Wu","year":"2014","journal-title":"Int J Biol Sci"},{"key":"key20200714003137_b5-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00262-007-0391-3","article-title":"Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas","volume":"57","author":"Bouet-Toussaint","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"key20200714003137_b6-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/eji.200838409","article-title":"DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells","volume":"39","author":"Toutirais","year":"2009","journal-title":"Eur J Immunol"},{"key":"key20200714003137_b7-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s00262-010-0887-0","article-title":"Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients","volume":"59","author":"Cabillic","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"key20200714003137_b8-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1080\/14653240802419328","article-title":"Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy","volume":"10","author":"Kondo","year":"2008","journal-title":"Cytotherapy"},{"key":"key20200714003137_b9-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/bjc.2011.293","article-title":"Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours","volume":"105","author":"Nicol","year":"2011","journal-title":"Br J Cancer"},{"key":"key20200714003137_b10-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.4049\/jimmunol.175.4.2144","article-title":"Activation of V gamma 9V delta 2 T cells by NKG2D","volume":"175","author":"Rincon-Orozco","year":"2005","journal-title":"J Immunol"},{"key":"key20200714003137_b11-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1365-2567.2012.03582.x","article-title":"Understanding the complexity of \u03b3\u03b4 T-cell subsets in mouse and human","volume":"136","author":"Pang","year":"2012","journal-title":"Immunology"},{"key":"key20200714003137_b12-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"key20200714003137_b13-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/10428190500051893","article-title":"Anti-lymphoma effect of gammadelta T cells","volume":"46","author":"Kunzmann","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"key20200714003137_b14-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"7287","DOI":"10.4049\/jimmunol.0804288","article-title":"Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes","volume":"182","author":"Todaro","year":"2009","journal-title":"J Immunol"},{"key":"key20200714003137_b15-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"10145","DOI":"10.1158\/0008-5472.CAN-06-1822","article-title":"Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res"},{"key":"key20200714003137_b16-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2006.04.015","article-title":"Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation","volume":"25","author":"Mempel","year":"2006","journal-title":"Immunity"},{"key":"key20200714003137_b17-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients","volume":"132","author":"Fu","year":"2007","journal-title":"Gastroenterology"},{"key":"key20200714003137_b18-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jhep.2012.12.015","article-title":"The functional impairment of HCC-infiltrating \u03b3\u03b4 T cells, partially mediated by regulatory T cells in a TGF\u03b2- and IL-10-dependent manner","volume":"58","author":"Yi","year":"2013","journal-title":"J Hepatol"},{"key":"key20200714003137_b19-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","article-title":"\u03b3\u03b4T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer","volume":"40","author":"Wu","year":"2014","journal-title":"Immunity"},{"key":"key20200714003137_b20-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1158\/0008-5472.CAN-13-2534","article-title":"IL-17A produced by \u03b3\u03b4 T cells promotes tumor growth in hepatocellular carcinoma","volume":"74","author":"Ma","year":"2014","journal-title":"Cancer Res"},{"key":"key20200714003137_b21-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma","volume":"100","author":"Llovet","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"key20200714003137_b22-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1182\/blood-2002-12-3665","article-title":"Gammadelta T cells for immune therapy of patients with lymphoid malignancies","volume":"102","author":"Wilhelm","year":"2003","journal-title":"Blood"},{"key":"key20200714003137_b23-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.1158\/0008-5472.CAN-07-0199","article-title":"Targeting human{gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer","volume":"67","author":"Dieli","year":"2007","journal-title":"Cancer Res"},{"key":"key20200714003137_b24-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00262-008-0521-6","article-title":"In vivo effects of zoledronic acid on peripheral T lymphocytes in early breast cancer patients","volume":"58","author":"Santini","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"key20200714003137_b25-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00262-008-0491-8","article-title":"Phase-I study of innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma","volume":"57","author":"Bennouna","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"key20200714003137_b26-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fimmu.2014.00643","article-title":"Monitoring circulating \u03b3\u03b4 T cells in cancer patients to optimize \u03b3\u03b4 T cell-based immunotherapy","volume":"5","author":"Oberg","year":"2014","journal-title":"Front Immunol"},{"key":"key20200714003137_b27-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1182\/blood-2003-05-1655","article-title":"Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo","volume":"102","author":"Dieli","year":"2003","journal-title":"Blood"},{"key":"key20200714003137_b28-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1006\/clim.2002.5218","article-title":"Human gammadelta T cells induce dendritic cell maturation","volume":"103","author":"Ismaili","year":"2002","journal-title":"Clin Immunol"},{"key":"key20200714003137_b29-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4049\/jimmunol.174.1.252","article-title":"Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: Role of CD86 and inflammatory cytokines","volume":"174","author":"Conti","year":"2005","journal-title":"J Immunol"},{"key":"key20200714003137_b30-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.4049\/jimmunol.176.3.1386","article-title":"Potentiation of antigen-stimulated V Gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation","volume":"176","author":"Devilder","year":"2006","journal-title":"J Immunol"},{"key":"key20200714003137_b31-ol-0-0-8026","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.25429","article-title":"Regulatory T cells in tumor immunity","volume":"127","author":"Nishikawa","year":"2010","journal-title":"Int J Cancer"},{"key":"key20200714003137_b32-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"e21816","DOI":"10.1371\/journal.pone.0021816","article-title":"Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"key":"key20200714003137_b33-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"key20200714003137_b34-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"key20200714003137_b35-ol-0-0-8026","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T03:55:50Z","timestamp":1719806150000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.8026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,12]]},"references-count":35,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.8026","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,12]]}}}